Cholesterol, statins, and mortality

The Lancet

Volumn 371, Issue 9619, 2008, Pages 1161-

  Ong, HT ^a   Haniffah, AG ^b  

^a HT Ong Heart Clinic   (Malaysia)

^b Island Hospital   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CANCER INCIDENCE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; LETTER; META ANALYSIS; MORTALITY; NEOPLASM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 41449113373     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60515-2     Document Type: Letter

References (5)

1. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370 (2007) 1829-1839
2. The Stroke Prevention by aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
3. Thrift A., Dewey H., Macdonell R., McNeil J., and Donnan G. Incidence of the major stroke subtypes: Initial findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 32 (2001) 1732-1738
4. Iso H., Jacobs Jr. D., Wentworth D., Neaton J., and Cohen J. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (1989) 904-910
5. Armitage J. The safety of statins in clinical practice. Lancet 370 (2007) 1781-1790